PROTALIX BIOTHERAPEUTICS, INC. (PLX)

[Kronberg]

According to the original contract, the Pfizer paid $ 60m to Protalix and they divided the future Elelyso sales corresponding 60 and 40%.Ex-Brazil global rights cost Pfizer approximately $110m including these $60m. This was my post where the Elelyso' price was quoted about $ 475,000 per patient per year. I’m too lazy to search, but this number is very close to the real one that was given on some website. I agree with King that Brazil cannot pay that kind of money but $ 100,000 is less than 25 % of drug prices in developed countries.I really hope PRX-102 will get AA FDA status, otherwise IMO we will see a new partnership for OPRX-106 until the end of this year.